Technology is all around us. Some of it is even starting to look a bit unreal. Eric Topol, in his book “The Patient Will See You Now - The Future of Medicine Is in Your Hands”,
Arvind Krishnamurthy, Vijayalakshmi Ramshankar, Kanchan Murhekar, Vidyarani Shyamsundar, Pavithra B Desai, Purvish Parikh (Department of Surgical Oncology, Cancer Institute (WIA), Adyar, Chennai, India, Department Preventive Oncology Research, Cancer Institute (WIA), Adyar, Chennai, India, Department of Pathology, Cancer Institute (WIA), Adyar,
As India enters a new phase of ‘Unlock 1.0’ completing the 4th phase of the lockdown the nation saw yet another spike in its COVID numbers with 8,392 new cases reported on June 1.
The Indian multinational pharmaceutical company, Sun Pharma has recently received approval from the Drugs Controller General of India (DCGI) for conducting clinical trials of a synthetic serine protease inhibitor, nafamostat mesylate against COVID-19.
The US FDA has approved turoctocog alfa pegol, N8-GP (Esperoct) for the treatment of adults and children with haemophilia A.
